TT Electronis has been working with iAbra, a Bedforshire start-up, and its partners to launch a Covid-19 screening device that gives results within 20 seconds. Together with Intel, the companies designed, developed and tested the prototype Virolens system.
The device uses microscopic holographic imaging and artificial intelligence (AI) software technology to detect the presence of the Covid-19 virus from a non-intrusive saliva swab test within 20 seconds. The test does not need to be administered by healthcare professionals and is expected to be used in airports, offices, sports venues and many other locations.
Headquartered in Woking, TT has been appointed exclusive manufacturing partner for the commercial launch of Virolens. It will be manufactured at the company’s Hartlepool factory and TT will invest £5 million to support the launch phase.
“I am proud that we are a core part of the team behind the ground-breaking Virolens programme. This project is evidence of the success of our strategy to position the business in higher technology, structural growth markets, using our engineering expertise to develop products in collaboration with our customers,” said Richard Tyson, TT chief executive.